Savlon

Kolkata, India Founded: 2005 • Age: 21 yrs Listed Acquired By ITC
Sanitizer and antiseptic liquids are manufactured by Savlon.
Request Access
Report Incorrect Data
Page last updated

About Savlon

Savlon is a publicly listed company based in Kolkata (India) founded in 2005, and was acquired by ITC in February 2015. Sanitizer and antiseptic liquids are manufactured by Savlon. It operates on a Direct-to-Consumer (D2C) model. The company has 28,205 employees. Its website savlon.in draws about 10 thousand monthly visits. Its Indian entity Itc Limited reported revenue of ₹84,927 Cr. Savlon offers products and services including Antiseptic Liquid, Deep Clean Handwash, Moisture Shield Handwash, Herbal Sensitive Handwash, and Glycerin Soap. Its focus areas include Consumer Goods, Personal Care and Hygiene Products. Its competitors include Aristocrat HAND SANITIZER, Bufin Soap Strips and JSR Amenities.

Company details

Savlon, operated by ITC Limited, is focused on delivering hygiene and germ protection solutions across India. Products such as antiseptic liquids, handwashes, soaps, and disinfectants are offered to ensure safety against germs. The range is trusted by healthcare professionals and has been developed for over 50 years to cater to personal and household hygiene needs. Various sectors including personal care and home sanitation are served through innovative and effective solutions.

  • Headquarters Kolkata, India
  • Employees 28,205
  • Stage Acquired
  • Sectors
    Consumer
  • Phone
    •••• ••••
  • Website savlon.in
  • Social X Facebook
  • Acquired by ITC (Feb 2015)
  • Legal Name Itc Limited
  • Date of Incorporation 24 Aug, 1910
  • Jurisdiction Kolkata, West Bengal, India
Operational Areas
Consumer → Beauty & Personal Care Products
Key Metrics
  • Market Cap
    ₹3,49,390 Cr

    ITC · NSE

  • Share Price
    ₹285.00

    +2.22% today

  • Revenue
    ₹78,868 Cr

    FY 2025-26 · +4.7% YoY

  • EBITDA
    ₹27,026 Cr

    Margin 34.3%

  • Net Profit
    ₹20,899 Cr

    FY 2025-26 · -39.6% YoY

  • P/E (TTM)
    18.5x

    P/B 4.9x

  • ROE
    29.5%

    ROCE 38.3%

  • Debt / Equity
    0.02

    Interest cover 0.3x

  • Investors
    ITC
  • Employee Count
    28,205
  • Acquired by
    ITC

    (Feb 2015)

Products & Services of Savlon

Savlon offers a comprehensive portfolio of products and services, including Antiseptic Liquid, Deep Clean Handwash, Moisture Shield Handwash, Herbal Sensitive Handwash, and Glycerin Soap.

Antiseptic Liquid
Hygiene Product

Antiseptic liquid trusted by doctors for germ protection.

Deep Clean Handwash
Hygiene Product

Handwash designed for deep cleaning against tough germs.

Moisture Shield Handwash
Hygiene Product

Handwash offering germ protection while keeping hands soft.

Herbal Sensitive Handwash
Hygiene Product

Handwash for sensitive hands with effective germ protection.

Glycerin Soap
Hygiene Product

Soap protecting against germs causing numerous common diseases.

Investors in Savlon

Savlon has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include ITC.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
ITC
Diverse products in FMCG, hotels, packaging, and agri-business are offered.
1910itcportal.comKolkata, India
Premium access

Investor details for Savlon

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Itc Limited (Savlon)

Itc Limited is the primary company behind Savlon. The board of Itc Limited currently have 16 directors; the longest-serving is Sanjiv Puri, appointed in 2015. 40 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sanjiv Puri
DIN 00280529
Managing Director06 Dec 201510 yrs 11 moItc Limited
Sumant Bhargavan
DIN 01732482
Whole-time director16 Nov 20187 yrs 11 moItc Limited
Ajit Kumar Seth
DIN 08504093
Director13 Jul 20197 yrs 4 moItc Limited
Anand Nayak
DIN 00973758
Director13 Jul 20197 yrs 4 moItc Limited
Sunil Panray
DIN 09251023
Director11 Aug 20215 yrs 3 moItc Limited
Shyamal Mukherjee
DIN 03024803
Director11 Aug 20215 yrs 3 moItc Limited
Hemant Bhargava
DIN 01922717
Director20 Dec 20214 yrs 10 moItc Limited
Supratim Dutta
DIN 01804345
Whole-time director22 Jul 20224 yrs 3 moItc Limited
Alka Marezban Bharucha
DIN 00114067
Director12 Aug 20233 yrs 3 moItc Limited
Hemant Malik
DIN 06435812
Whole-time director12 Aug 20233 yrs 3 moItc Limited
Atul Singh
DIN 00060943
Director02 Apr 20242 yrs 7 moItc Limited
Pushpa Subrahmanyam
DIN 01894076
Director02 Apr 20242 yrs 7 moItc Limited
Chandra Kishore Mishra
DIN 02553126
Director14 Sep 20242 yrs 1 moItc Limited
Siddhartha Mohanty
DIN 08058830
Director01 Jan 20251 yr 10 moItc Limited
Amitabh Kant
DIN 00222708
Director01 Jan 202610 moItc Limited
Navin Agarwal
DIN 10684167
Director01 Apr 20267 moItc Limited

IPO & Listings of Savlon

Savlon is a publicly listed company on the NSE with ticker symbol ITC in India, operating in the Tobacco Products sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • Listed onNSE: ITC
  • Listed entityItc Limited
  • Exchange sectorTobacco Products

Financials of Savlon

Exchange-reported figures of Itc Limited, the listed company behind Savlon (NSE: ITC).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹78,868 Cr
+4.7% YoY
EBITDA
₹27,026 Cr
+4.1% YoY
Profit After Tax
₹20,899 Cr
-39.6% YoY
Net Worth
₹72,507 Cr
+3.5% YoY
Total Assets
₹76,214 Cr
+6.9% YoY
Total Debt
₹2,399 Cr
+743.1% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue78,86875,32367,93270,93760,66849,27349,404
Revenue growth+4.7%+10.9%-4.2%+16.9%+23.1%-0.3%-
EBITDA27,02625,97025,25025,70020,67917,00919,155
EBITDA margin+34.3%+34.5%+37.2%+36.2%+34.1%+34.5%+38.8%
Profit before tax28,03341,94326,96125,91520,74017,93820,035
Net profit20,89934,58520,41119,14015,20113,20315,448
Net profit margin+26.5%+45.9%+30.1%+27.0%+25.1%+26.8%+31.3%
EPS (₹)16.5127.7716.3915.4412.3710.6912.45
Balance sheet
Total assets76,21471,32176,06570,60463,47361,45266,248
Net worth72,50770,03074,50769,15562,45660,34765,273
Total debt2,399285303306249271277
Cash & bank3,0094,0127,2184,8804,6544,6597,277
Net working capital15,46913,41914,5028,7889,8559,51412,065
Cash flow
Cash from operations18,46417,62717,17918,87815,77612,52714,690
Cash from investing(2,321)(564)1,563(5,732)(2,238)5,740(6,174)
Cash from financing(16,147)(17,037)(18,551)(13,006)(13,580)(18,634)(8,181)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue20,26919,11417,82520,04719,50221,49518,76518,790
Revenue growth (YoY)+3.9%-11.1%-5.0%+6.7%-2.4%+20.9%--
Other income6041,14872567673975115,391803
EBITDA5,6195,1816,8996,5286,6956,8166,5196,362
EBITDA margin+27.9%+27.3%+39.1%+32.8%+34.7%+31.9%+35.1%+34.2%
Depreciation491428422431435423411416
Interest38.2739.7829.1819.4720.0516.4710.919.82
Profit before tax5,6955,8617,1736,7546,9797,12821,4896,740
Tax1,4651,3521,7031,7361,7921,7851,6811,726
Net profit4,2294,5095,4705,0185,1875,34319,8085,013
EPS (₹)3.323.514.303.944.094.1815.753.94
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue71,98469,32662,62866,04356,34145,48545,620
Revenue growth+3.8%+10.7%-5.2%+17.2%+23.9%-0.3%-
EBITDA25,02424,01523,49423,97618,95215,53417,797
EBITDA margin+34.8%+34.6%+37.5%+36.3%+33.6%+34.2%+39.0%
Profit before tax26,76841,63426,14424,75019,83017,16419,167
Net profit20,41734,65919,86418,70215,01313,07415,279
Net profit margin+28.4%+50.0%+31.7%+28.3%+26.7%+28.7%+33.5%
EPS (₹)16.1928.1316.3615.0912.2210.5912.31
Balance sheet
Total assets72,72468,36472,87768,27361,99459,73064,595
Net worth69,92967,89472,23367,59461,40059,00564,029
Total debt2,162157312325311329332
Cash & bank2,1363,1856,2183,8313,8784,0026,843
Net working capital13,31511,38311,7866,4797,8867,64610,310
Cash flow
Cash from operations17,09516,75416,11817,91214,80811,49413,806
Cash from investing(1,538)36.062,128(5,159)(1,517)6,555(5,517)
Cash from financing(15,694)(16,766)(18,255)(12,730)(13,337)(18,379)(7,891)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue18,40116,90816,05018,09218,02119,76117,24917,053
Revenue growth (YoY)+2.1%-14.4%-7.0%+6.1%-3.4%+20.7%--
Other income8086456551,07398666215,4821,831
Total expenses13,26712,3939,62512,09411,76913,50011,26211,224
EBITDA5,1344,5146,4265,9976,2526,2615,9875,828
EBITDA margin+28.2%+26.9%+40.6%+33.4%+35.1%+31.9%+35.2%+34.7%
Depreciation428366362372371366356362
Interest31.7633.7824.4015.3815.8813.408.517.57
Profit before tax5,4824,7596,6946,6836,8516,54321,1047,290
Tax1,3451,1811,5811,5961,6721,6331,5421,652

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 11 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue20,26919,11417,82520,04719,50221,49518,76518,790
Revenue growth (YoY)+3.9%-11.1%-5.0%+6.7%-2.4%+20.9%--
Other income6041,14872567673975115,391803
EBITDA5,6195,1816,8996,5286,6956,8166,5196,362
EBITDA margin+27.9%+27.3%+39.1%+32.8%+34.7%+31.9%+35.1%+34.2%
Depreciation491428422431435423411416
Interest38.2739.7829.1819.4720.0516.4710.919.82
Profit before tax5,6955,8617,1736,7546,9797,12821,4896,740
Tax1,4651,3521,7031,7361,7921,7851,6811,726
Net profit4,2294,5095,4705,0185,1875,34319,8085,013
EPS (₹)3.323.514.303.944.094.1815.753.94
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue78,86875,32367,93270,93760,66849,27349,404
Revenue growth+4.7%+10.9%-4.2%+16.9%+23.1%-0.3%-
Other income2,80317,6643,2682,1021,8542,6332,606
Total expenses51,84249,35342,68245,23739,98932,26430,249
Employee cost6,7826,1705,5495,7364,8914,4634,296
EBITDA27,02625,97025,25025,70020,67917,00919,155
EBITDA margin+34.3%+34.5%+37.2%+36.2%+34.1%+34.5%+38.8%
Depreciation1,7111,6461,5181,8091,7321,6461,645
Interest85.1745.0639.1177.7759.9957.9781.38
Profit before tax28,03341,94326,96125,91520,74017,93820,035
Tax7,0156,8906,2096,4385,2374,5554,442
Net profit20,89934,58520,41119,14015,20113,20315,448
Net profit margin+26.5%+45.9%+30.1%+27.0%+25.1%+26.8%+31.3%
EPS (₹)16.5127.7716.3915.4412.3710.6912.45
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital1,2531,2511,2481,2431,2321,2311,229
Reserves & surplus71,25468,77973,25967,91261,22359,11664,044
Shareholders' funds (net worth)72,50770,03074,50769,15562,45660,34765,273
Minority interest366368383384366347377
Secured loans1.970.000.0033.960.003.881.42
Unsecured loans2,397285303272249267276
Total debt2,399285303306249271277
Total liabilities76,21471,32176,06570,60463,47361,45266,248
Assets
Gross block35,67233,63840,18936,60833,43531,08827,965
Net block22,44321,95527,82025,85124,23223,29821,713
Capital work in progress1,6021,0912,8613,0033,2264,0113,256
Investments38,12834,72031,11429,41524,84124,87128,663
Inventories18,62315,63814,15311,77110,86410,3978,879
Sundry debtors3,9234,7204,0262,9562,4622,5022,562
Cash & bank balances3,0094,0127,2184,8804,6544,6597,277
Loans & advances4,4033,2362,7252,8313,9882,5882,838
Total current assets29,95827,60628,12122,43821,96820,14621,557
Total current liabilities14,48914,18713,61913,65012,11310,6319,492
Net working capital15,46913,41914,5028,7889,8559,51412,065
Total assets76,21471,32176,06570,60463,47361,45266,248
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash622597406267310677343
Net cash from operating activities18,46417,62717,17918,87815,77612,52714,690
Net cash from investing activities(2,321)(564)1,563(5,732)(2,238)5,740(6,174)
Net cash from financing activities(16,147)(17,037)(18,551)(13,006)(13,580)(18,634)(8,181)
Net change in cash(3.55)25.80191139(43.48)(367)334
Closing cash3,0094,0127,2184,8804,6544,6597,277
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+4.7%+10.9%-4.2%+16.9%+23.1%-0.3%-
EBITDA growth+4.1%+2.9%-1.8%+24.3%+21.6%-11.2%-
PBT growth-33.2%+55.6%+4.0%+25.0%+15.6%-10.5%+4.6%
Net income growth-39.6%+69.4%+6.6%+25.9%+15.1%-14.5%-
Revenue CAGR (3Y)+3.6%+7.5%+11.3%+12.8%+7.9%+4.3%+4.9%
EBITDA CAGR (3Y)+1.7%+7.9%+14.1%+10.3%+3.9%+1.0%+7.4%
Profitability & leverage
Net income margin+26.7%+46.5%+30.6%+27.5%+25.6%+27.2%+31.6%
Return on capital employed+38.3%+36.6%+37.0%+39.0%+33.5%+28.4%+32.1%
Return on net worth+29.5%+48.3%+28.9%+29.6%+25.3%+21.3%+25.1%
Debt / equity0.020.000.000.000.000.000.00
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover0.340.190.160.330.320.380.46
Efficiency & per share
Fixed asset turnover2.592.211.922.182.021.801.97
Inventory turnover5.255.485.706.766.135.526.14
Debtors turnover20.8118.6621.1728.2526.2720.9915.58
EPS (₹)16.5127.7716.3915.4412.3710.6912.45
Dividend per share (₹)14.5014.3513.7515.5011.5010.7510.15
Book value per share (₹)57.8755.9659.6855.6450.6849.0353.10
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue18,40116,90816,05018,09218,02119,76117,24917,053
Revenue growth (YoY)+2.1%-14.4%-7.0%+6.1%-3.4%+20.7%--
Other income8086456551,07398666215,4821,831
Total expenses13,26712,3939,62512,09411,76913,50011,26211,224
EBITDA5,1344,5146,4265,9976,2526,2615,9875,828
EBITDA margin+28.2%+26.9%+40.6%+33.4%+35.1%+31.9%+35.2%+34.7%
Depreciation428366362372371366356362
Interest31.7633.7824.4015.3815.8813.408.517.57
Profit before tax5,4824,7596,6946,6836,8516,54321,1047,290
Tax1,3451,1811,5811,5961,6721,6331,5421,652
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue71,98469,32662,62866,04356,34145,48545,620
Revenue growth+3.8%+10.7%-5.2%+17.2%+23.9%-0.3%-
Other income3,28719,0984,0422,5102,5903,2513,014
Total expenses46,95945,31139,13442,06737,38929,95127,823
Employee cost3,6293,4173,2013,5693,0622,8212,658
EBITDA25,02424,01523,49423,97618,95215,53417,797
EBITDA margin+34.8%+34.6%+37.5%+36.3%+33.6%+34.2%+39.0%
Depreciation1,4741,4421,3571,6631,6521,5621,563
Interest69.9436.3534.3973.5860.5358.9480.44
Profit before tax26,76841,63426,14424,75019,83017,16419,167
Tax6,4816,4375,7225,9974,7724,1334,031
Net profit20,41734,65919,86418,70215,01313,07415,279
Net profit margin+28.4%+50.0%+31.7%+28.3%+26.7%+28.7%+33.5%
EPS (₹)16.1928.1316.3615.0912.2210.5912.31
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital1,2531,2511,2481,2431,2321,2311,229
Reserves & surplus68,67666,64270,98566,35160,16757,77462,800
Shareholders' funds (net worth)69,92967,89472,23367,59461,40059,00564,029
Secured loans1.970.000.000.000.000.000.00
Unsecured loans2,160157312325311329332
Total debt2,162157312325311329332
Total liabilities72,72468,36472,87768,27361,99459,73064,595
Assets
Gross block32,58830,77637,30434,26131,87229,47826,341
Net block20,47219,99025,74324,17423,22122,18820,518
Capital work in progress1,5541,0711,0871,6972,4663,3332,780
Investments39,11135,98334,73932,72127,28226,98430,631
Inventories17,93215,06112,63210,5949,9989,4718,038
Sundry debtors2,9263,9113,3112,3211,9522,0902,092
Cash & bank balances2,1363,1856,2183,8313,8784,0026,843
Loans & advances3,4492,3121,9932,1003,4892,2062,359
Total current assets26,44224,46824,15418,84619,31717,76919,332
Total current liabilities13,12713,08512,36712,36811,43110,1229,022
Net working capital13,31511,38311,7866,4797,8867,64610,310
Total assets72,72468,36472,87768,27361,99459,73064,595
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash222198207185231561163
Net cash from operating activities17,09516,75416,11817,91214,80811,49413,806
Net cash from investing activities(1,538)36.062,128(5,159)(1,517)6,555(5,517)
Net cash from financing activities(15,694)(16,766)(18,255)(12,730)(13,337)(18,379)(7,891)
Net change in cash(138)24.34(9.25)21.90(46.30)(330)399
Closing cash2,1363,1856,2183,8313,8784,0026,843
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+3.8%+10.7%-5.2%+17.2%+23.9%-0.3%-
EBITDA growth+4.2%+2.2%-2.0%+26.5%+22.0%-12.7%-
PBT growth-35.7%+59.3%+5.6%+24.8%+15.5%-10.5%+3.9%
Net income growth-41.1%+74.5%+6.2%+24.6%+14.8%-14.4%-
Revenue CAGR (3Y)+2.9%+7.2%+11.3%+13.1%+7.8%+3.8%+4.4%
EBITDA CAGR (3Y)+1.4%+8.2%+14.8%+10.4%+3.0%-0.1%+6.8%
Profitability & leverage
Net income margin+28.2%+50.8%+32.6%+28.4%+26.7%+28.7%+33.2%
Return on capital employed+38.0%+36.7%+37.1%+38.1%+32.7%+27.7%+31.4%
Return on net worth+29.4%+27.9%+29.2%+29.1%+25.0%+21.2%+24.8%
Debt / equity0.020.000.000.000.010.010.00
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover0.300.160.160.330.350.420.50
Efficiency & per share
Fixed asset turnover2.582.181.882.121.951.741.90
Inventory turnover4.955.365.796.826.145.545.99
Debtors turnover23.8820.5623.8932.8829.5623.2016.31
EPS (₹)16.1928.1316.3615.0912.2210.5912.31
Dividend per share (₹)14.5014.3513.7515.5011.5010.7510.15
Book value per share (₹)55.8154.2557.8654.3949.8247.9452.09

Timeline of Savlon

2 dated milestones of Savlon across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Savlon is founded.
  2. Exit Acquired by ITC.

Competitors of Savlon

Savlon has 3 listed competitors in our database. They include Aristocrat HAND SANITIZER, Bufin Soap Strips and JSR Amenities.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
Aristocrat HAND SANITIZER
aristocratindia.com2020Delhi, India1,774
Operates a direct-to-consumer brand offering hand sanitizers.
Bufin Soap Strips
bufin.com1972Nashik, India3
Manufactures and supplies hygiene products including soap strips and sanitizers.
JSR Amenities
jsramenities.com2017Delhi, India
Manufactures and supplies luxury hotel toiletries and guest room amenities to chains.
Premium access

Detailed competitors of Savlon

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Savlon

The website of Savlon (savlon.in) receives about 10.1K visits a month.

  • Monthly visits
    10.1K

    ▼ 25.7% vs previous month

Similar websites

Websites whose visitors overlap most with Savlon. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
Vedi Herbals
vediherbals.com
100%
44.3K#673,440View details
weherbal.in
weherbal.in
83%
#782,697–
Krishna's Herbal & Ayurveda
krishnaayurved.com
57%
1.3M#63,068View details
Thanjai Orgofarms
thanjainatural.com
34%
View details
powersoaps.com
powersoaps.com
33%
#7,032,240–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 9 similar websites and full traffic analytics for Savlon

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 9 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Beauty & Personal Care Products

3 companies that operate in the same segment as Savlon (Beauty & Personal Care Products) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
FirstCry
Online platform offering a wide range of baby, kids, and maternity products
2010Pune, Maharashtra, IndiaUSD 513.39 MUSD 911.07 M3,752
Bombay Shaving
Online brand offering mens grooming products
2015Gurugram, Haryana, IndiaUSD 52.66 M
Bella Vita
Retailer of perfumes, cosmetics, skincare, and related gift set items
2012Gurugram, Haryana, IndiaUSD 60.63 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Savlon

ITC: Rs. 17.51 Crores NSE Block Trade; for ~ 629,685 Shares, at Rs. 278.15
Exchange Update • 3 days ago
ITC: JPMorgan on ITC maintains Neutral, Target Price Rs 310; Q2 EBITDA was 3% ahead of estimates, led by stronger non-cigarette businesses, while cigarette operations were broadly in line. Cigarette EBIT declined 27% YoY due to delayed price hikes and volume weakness. Portfolio restructuring and calibrated pricing actions are expected to gradually narrow the EBIT decline, with cigarette EBIT expected to stabilise by Q4.
Exchange Update • 9 days ago
ITC: Goldman Sachs on ITC maintains Neutral, Target Price Rs 290; Q2FY27 performance was broadly in line, supported by accelerating non-cigarette businesses. FMCG and Paper delivered strong revenue and margin performance, while cigarette EBIT decline moderated to 27% YoY. Goldman Sachs expects a gradual recovery in the cigarette business.
Exchange Update • 9 days ago
ITC: Jefferies on ITC maintains Buy, Target Price Rs 350; Cigarette volumes and EBIT continued to decline following sharp tax hikes, although management has taken measures to navigate the pressure. Calibrated price increases should support a gradual recovery, while FMCG and Paperboards delivered strong Q2 performance and Agri remained in line. Jefferies trimmed EPS estimates by 2–3% but expects sequential improvement in cigarette trends.
Exchange Update • 9 days ago
ITC: CLSA on ITC maintains Outperform, Target Price Rs 390; Q2 standalone revenue grew 3% YoY, while EBITDA declined 17% due to the unprecedented cigarette tax increase. Cigarette revenue and EBIT fell 21% and 27%, respectively, while non-cigarette businesses delivered 18% revenue and 23% EBITDA growth, led by FMCG, paperboards and agri. Portfolio interventions and calibrated pricing actions are aimed at limiting volume migration to illicit trade.
Exchange Update • 9 days ago
ITC: RS. 55.03 CRORES NSE BLOCK TRADE; FOR ~ 2,057,322 SHARES, AT RS. 267.50
Exchange Update • 9 days ago
ITC: Q2 REVENUE 283.18B RUPEES VS 194.4B (YOY); EST 182B
Exchange Update • 10 days ago
ITC: Q2 SL NET PROFIT 41.37B RUPEES VS 51.8B (YOY); EST 40.9B
Exchange Update • 10 days ago
ITC: Q2 EBITDA 51.34B RUPEES VS 62.52B (YOY), EST 51.6B; Q2 EBITDA MARGIN 18.13% VS 32.26%, EST 28.4%
Exchange Update • 10 days ago
FMCG Firms Face Margin Pressure In H2 As Palm Oil And Sugar Prices Rise (ITC, HUL, Nestlé)
Exchange Update • 24 days ago
Premium access

Complete news archive for Savlon

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Savlon

Savlon was founded in 2005.

Savlon is headquartered in Kolkata, India. It is registered at Kolkata, West Bengal, India.

Savlon has 28,205 employees.

The primary company behind Savlon, Itc Limited, reported revenue of ₹84,927 Cr for FY 2026, up 5% year on year.

Savlon, operated by ITC Limited, is focused on delivering hygiene and germ protection solutions across India. Products such as antiseptic liquids, handwashes, soaps, and disinfectants are offered to ensure safety against germs. The range is trusted by healthcare professionals and has been developed for over 50 years to cater to personal and household hygiene needs. Various sectors including personal care and home sanitation are served through innovative and effective solutions.

Savlon's top competitors include Bufin Soap Strips, Aristocrat HAND SANITIZER and JSR Amenities.

Savlon offers Antiseptic Liquid, Deep Clean Handwash, Moisture Shield Handwash, Herbal Sensitive Handwash, and Glycerin Soap.

Yes, Savlon is publicly traded on NSE under the ticker symbol ITC.

Savlon has 1 investor. Key investors include ITC.

Savlon operates through Itc Limited.

Yes. Savlon was acquired by ITC in February 2015.

The legal entities of Savlon currently have 17 directors, including Sanjiv Puri, Ajit Kumar Seth, Sumant Bhargavan and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available